Trials
Search / Trial NCT06430775

Exploring Prolonged AMR in ACL Reconstructed Patients

Launched by UNIVERSITY GHENT · May 21, 2024

Trial Information

Current as of February 19, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how certain factors affect the recovery of patients who have had surgery to repair a torn anterior cruciate ligament (ACL) in their knee. Specifically, the study will explore how feelings of fear about movement (called kinesiophobia), knee function, pain levels, and other clinical measures like swelling and muscle strength relate to a condition known as prolonged arthrogenic muscle responses (AMR). AMR is an unconscious muscle reaction that can happen after an injury, and the researchers want to see if patients with higher fear or pain levels experience AMR for a longer time.

If you are between 18 and 40 years old and have recently suffered an ACL rupture, you may be eligible to participate in this trial at AZ Delta hospital in Roeselare. Participants will need to complete several questionnaires about their knee function, activity levels, and pain before their surgery and again at one and three months afterward. Five months post-surgery, they will also undergo some physical tests to measure muscle responses during jumping tasks. This study aims to better understand ACL recovery to help improve rehabilitation approaches for future patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 18-40 years old.
  • Having suffered an ACL rupture.
  • Undergoing a surgical ACL reconstruction in the AZ Delta hospital in Roeselare (Campus Brugsesteenweg).
  • Exclusion Criteria:
  • Revision ACL reconstruction.
  • Other severe injuries to the lower limbs within the past year.
  • Muscular or neurological disorders affecting lower limb functioning.
  • Fibromyalgia or chronic fatigue syndrome.

About University Ghent

University Ghent is a prestigious Belgian research institution renowned for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a multidisciplinary approach, the university fosters collaboration among leading experts in various fields, ensuring rigorous study design and ethical standards. University Ghent is dedicated to exploring new therapeutic modalities and enhancing healthcare outcomes, making significant contributions to both local and global health landscapes. Its state-of-the-art facilities and emphasis on research excellence position it as a pivotal sponsor in the realm of clinical research.

Locations

Roeselare, West Vlaanderen, Belgium

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0